Pfizer and Dr. Reddy's have reached a settlement over the latter's efforts to launch a generic version of the world's top-selling drug, according to published reports.
Dr. Reddy’s Labs on Tuesday announced that it has launched its over-the-counter fexofenadine and pseudoephedrine extended-release tablets.
The Food and Drug Administration has approved a drug made by Johnson & Johnson for treating deep vein thrombosis in patients undergoing knee or hip replacement surgery, a J&J subsidiary said.
The Food and Drug Administration has approved a generic anticoagulant drug made by Dr. Reddy’s Labs and Alchemia.
Dr. Reddy’s Labs has launched a generic drug for treating high blood pressure, the company said Thursday.
Generic drug maker Dr. Reddy’s Labs has launched its version of a popular antibiotic.
The Food and Drug Administration Tuesday approved the first generic versions of an antibiotic designed to treat certain infections in people ages 18 years and older.
The Food and Drug Administration has issued a warning letter to Dr. Reddy’s Labs’ chemical manufacturing plant in Mexico, the company said Tuesday.
Dr. Reddy's Labs has received regulatory approval from the Food and Drug Administration for generic versions of treatments for Alzheimer's disease, depression and breast cancer.
The Food and Drug Administration has approved a dozen new generic versions of a drug used to treat breast cancer, the agency said Monday.
A generic drug maker is being sued for patent infringement for its version of a fixed-dose combination drug co-created by Pozen and AstraZeneca.
The Food and Drug Administration has approved Dr. Reddy's version of an allergy medication that recently received Rx-to-OTC switch approval, the generic drug maker said.
Dr. Reddy’s Labs will assume ownership of a penicillin manufacturing site in Bristol, Tenn., from GlaxoSmithKline.
Indian generic drug maker Dr. Reddy’s Labs has launched a generic treatment for seasonal allergies, the company said Tuesday.
A federal court has lifted an injunction that had prevented drug maker Dr. Reddy’s Labs from marketing a generic version of an allergy drug.
The Food and Drug Administration has approved a treatment for gastroesphageal reflux disease made by a subsidiary of Mylan, the generic drug maker said Monday.
Indian drug maker Dr. Reddy’s Labs has launched a generic treatment for gastroesophageal reflux disease.
A generic version of the world’s top-selling cholesterol treatment is expected to hit the market this year, but the branded version’s manufacturer is trying to put the brakes on the launch, according to media reports.
A generic drug maker has entered an agreement to purchase another drug maker's U.S. penicillin site ...
Indian generic drug maker Dr. Reddy’s Labs has launched a version of an asthma drug...
The world of generic drugs has a big year ahead of it. Actually, it has...
K-V Pharmaceutical has created a new marketing subsidiary for generic drugs, the company said. K-V...
Dr. Reddy's disclosed on Tuesday it will market a generic peptic ulcer treatment....
Winc Design is launching its Charlie Banana brand of environmentally friendly cloth diapers and baby...
The generics subsidiary of Pfizer is launching a new business focused on authorized generics. Greenstone...